Neuronal Cell Isolation via CD51 Negative Selection
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for isolating neuronal cells from cell suspensions, such as density gradient centrifugation and fluorescence-activated cell sorting, are cumbersome, costly, and result in low purities and significant cell loss, with no efficient method for direct magnetic separation of viable neurons due to the lack of a general neuron-specific cell surface marker.
Innovation Solution
Identification and utilization of CD51 as a pan-non-neuronal cell surface marker for negative selection, allowing for the enrichment, isolation, and detection of living neuronal cells by labeling non-neuronal cells with antibodies coupled to a solid phase, thereby isolating untouched neuronal cells.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If fluorescence-activated cell sorting is used to isolate neuronal cells, then cell type specificity is improved, but procedure complexity and cost increase significantly
Solution Approach 1:
The invention extracts and utilizes endogenous biotin expression patterns in neuronal cells to create a simplified sorting approach. By using streptavidin-conjugated magnetic beads to bind biotin, the method removes the need for complex transgenic mouse models and fluorescent protein expression systems, achieving neuronal cell isolation with basic magnetic separation equipment
Solution Approach 2:
The invention uses streptavidin-conjugated magnetic beads as a copy of the biotin-binding system that naturally exists in neuronal cells. This allows the natural biotin expression pattern to be utilized for sorting without requiring genetic modification, simplifying the overall procedure while maintaining cell type specificity
2Measurement precision
If transgenic mice with fluorescent markers are used for neuronal cell isolation, then cell type specificity is improved, but time consumption and cost increase
Solution Approach 1:
The invention takes advantage of the preliminary action of endogenous biotin expression that is already present in neuronal cells. By utilizing this pre-existing molecular marker, the method eliminates the time-consuming process of generating and maintaining transgenic mouse lines, achieving rapid neuronal cell isolation within hours rather than weeks or months
3Ease of manufacture
If density gradient centrifugation is used for cell separation, then equipment simplicity is maintained, but purification quality and cell viability deteriorate
Solution Approach 1:
The invention introduces streptavidin-conjugated magnetic beads as an intermediary between the simple centrifugation equipment and the target neuronal cells. These beads specifically bind to biotin on neuronal cell surfaces, enabling high-purity separation through magnetic selection while maintaining equipment simplicity and avoiding the cell damage associated with complex centrifugation protocols
4Productivity
If magnetic activated cell sorting is used with direct neuronal markers, then separation efficiency is improved, but applicability deteriorates due to lack of general neuron-specific markers
Solution Approach 1:
The invention inverts the approach by using streptavidin-conjugated magnetic beads to bind endogenous biotin that is naturally expressed in neuronal cells. This reverse strategy allows direct magnetic separation of neuronal cells using a universally applicable biotin-streptavidin interaction, eliminating the need to identify and validate new neuron-specific markers for each experimental system
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This method achieves high purity neuronal cell isolation with minimal contamination, enabling the isolation of all neuronal subtypes from mixed neural cell suspensions, surpassing the limitations of existing techniques by using CD51 as a marker for negative selection.
Implementation Method 1
contacting a sample containing neuronal cells with an antigen-binding fragment such as an antibody or an antibody fragment specific for the CD51 antigen coupled to a solid phase thereby labelling CD51 positive cells of said sample
Implementation Method 2
magnetic separation of cells, e.g. the magnetic activated cell sorting (MACS technology)
Data Source
AI summary
The present invention provides the use of the cell surface antigen CD51 as a negative selection marker for neuronal cells and a method for enrichment, isolation and/or detection of neuronal cells comprising the steps a) contacting a sample containing neuronal cells with an antigen-binding fragment specific for the CD51 antigen coupled to a solid phase, thereby labelling the CD51 positive cells of said sample and b) isolating the non-labelled cells of said sample.